Global X Funds > Global X Funds
Global X Genomics & Biotechnology ETF
$185.22M
Avg Monthly Net Assets
$92.76M
Total Assets
$41K
Total Liabilities
$92.72M
Net Assets
Global X Genomics & Biotechnology ETF is an Exchange-Traded Fund in Global X Funds
from Global X Funds,
based in Pennsylvania,
United States of America.
The fund has one share class
and monthly net assets of $185.22M.
On July 30th, 2024 it reported 42 holdings, the largest
being MODERNA, INC. (5.1%), BIO-TECHNE CORPORATION (4.8%) and NATERA, INC. (4.6%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| Global X Genomics & Biotechnology ETF | C000203266 | XNAS | GNOM |
Holdings
From latest NPORT-P, filed July 30th, 2024 for period ending May 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 10X GENOMICS INC-CLASS A COMMON STOCK | Long | Equity-common | US | $3M | 132K | 3.20 |
| 2SEVENTY BIO INC COMMON STOCK | Long | Equity-common | US | $358K | 85K | 0.39 |
| AGILENT TECHNOLOGIES INC COMMON STOCK (AGILENT TECHNOLOGIES, INC.) | Long | Equity-common | US | $3M | 26K | 3.72 |
| ALLOGENE THERAPEUTICS INC COMMON STOCK | Long | Equity-common | US | $469K | 188K | 0.51 |
| ALNYLAM PHARMACEUTICALS INC COMMON STOCK (ALNYLAM PHARMACEUTICALS, INC.) | Long | Equity-common | US | $4M | 25K | 4.05 |
| ARROWHEAD PHARMACEUTICALS IN COMMON STOCK (ARROWHEAD PHARMACEUTICALS, INC.) | Long | Equity-common | US | $4M | 156K | 3.87 |
| AVIDITY BIOSCIENCES INC COMMON STOCK | Long | Equity-common | US | $3M | 128K | 3.72 |
| BEAM THERAPEUTICS INC COMMON STOCK | Long | Equity-common | US | $3M | 122K | 3.13 |
| BIO-TECHNE CORP COMMON STOCK (BIO-TECHNE CORPORATION) | Long | Equity-common | US | $4M | 57K | 4.77 |
| BIOMARIN PHARMACEUTICAL INC COMMON STOCK (BIOMARIN PHARMACEUTICAL INC.) | Long | Equity-common | US | $3M | 40K | 3.23 |
| BIONTECH SE-ADR DEPOSITARY RECEIPT | Long | Equity-common | US | $4M | 41K | 4.48 |
| BLUEBIRD BIO INC COMMON STOCK (BLUEBIRD BIO, INC.) | Long | Equity-common | US | $304K | 336K | 0.33 |
| BNYREPOS | Long | Repurchase agreement | US | $1M | – | 1.36 |
| CAREDX INC COMMON STOCK (CAREDX, INC.) | Long | Equity-common | US | $1M | 87K | 1.23 |
| CARIBOU BIOSCIENCES INC COMMON STOCK | Long | Equity-common | US | $401K | 139K | 0.43 |
| CRISPR THERAPEUTICS AG COMMON STOCK | Long | Equity-common | US | $4M | 65K | 3.79 |
| EDITAS MEDICINE INC COMMON STOCK (EDITAS MEDICINE, INC.) | Long | Equity-common | US | $751K | 144K | 0.81 |
| FULGENT GENETICS INC COMMON STOCK (FULGENT GENETICS, INC.) | Long | Equity-common | US | $736K | 36K | 0.79 |
| GENSCRIPT BIOTECH CORP COMMON STOCK | Long | Equity-common | HK | $2M | 2M | 2.68 |
| GILEAD SCIENCES INC COMMON STOCK (GILEAD SCIENCES, INC.) | Long | Equity-common | US | $2M | 27K | 1.87 |
| ILLUMINA INC COMMON STOCK (ILLUMINA, INC.) | Long | Equity-common | US | $3M | 30K | 3.33 |
| INTELLIA THERAPEUTICS INC COMMON STOCK (INTELLIA THERAPEUTICS, INC.) | Long | Equity-common | US | $4M | 169K | 3.91 |
| LEGEND BIOTECH CORP-ADR DEPOSITARY RECEIPT | Long | Equity-common | US | $3M | 81K | 3.48 |
| LYELL IMMUNOPHARMA INC COMMON STOCK | Long | Equity-common | US | $581K | 210K | 0.63 |
| MODERNA INC COMMON STOCK (MODERNA, INC.) | Long | Equity-common | US | $5M | 33K | 5.14 |
| MYRIAD GENETICS INC COMMON STOCK (MYRIAD GENETICS, INC.) | Long | Equity-common | US | $4M | 155K | 3.80 |
| NATERA INC COMMON STOCK (NATERA, INC.) | Long | Equity-common | US | $4M | 40K | 4.57 |
| PACIFIC BIOSCIENCES OF CALIF COMMON STOCK (PACIFIC BIOSCIENCES OF CALIFORNIA, INC.) | Long | Equity-common | US | $827K | 462K | 0.89 |
| POSEIDA THERAPEUTICS INC COMMON STOCK | Long | Equity-common | US | $388K | 130K | 0.42 |
| QIAGEN N.V. COMMON STOCK | Long | Equity-common | US | $4M | 88K | 4.09 |
| REGENXBIO INC COMMON STOCK | Long | Equity-common | US | $1M | 79K | 1.22 |
| ROCKET PHARMACEUTICALS INC COMMON STOCK (ROCKET PHARMACEUTICALS, INC.) | Long | Equity-common | US | $3M | 151K | 3.47 |
| SANA BIOTECHNOLOGY INC COMMON STOCK | Long | Equity-common | US | $2M | 215K | 1.74 |
| SAREPTA THERAPEUTICS INC COMMON STOCK (SAREPTA THERAPEUTICS, INC.) | Long | Equity-common | US | $4M | 29K | 4.10 |
| SCILEX HOLDING CO - RESTRICTED SPECIAL PURPOSE ACQUISITION COMPANIES | Long | Equity-common | US | $61K | 226K | 0.07 |
| TAKARA BIO INC COMMON STOCK (TAKARA BIO INC.) | Long | Equity-common | JP | $548K | 84K | 0.59 |
| ULTRAGENYX PHARMACEUTICAL IN COMMON STOCK (Ultragenyx Pharmaceutical Inc) | Long | Equity-common | US | $3M | 82K | 3.56 |
| UNIQURE NV COMMON STOCK | Long | Equity-common | US | $383K | 77K | 0.41 |
| VERACYTE INC COMMON STOCK | Long | Equity-common | US | $3M | 133K | 2.97 |
| VERTEX PHARMACEUTICALS INC COMMON STOCK (VERTEX PHARMACEUTICALS INCORPORATED) | Long | Equity-common | US | $2M | 5K | 2.22 |
| VERVE THERAPEUTICS INC COMMON STOCK | Long | Equity-common | US | $505K | 97K | 0.54 |
| VIR BIOTECHNOLOGY INC COMMON STOCK | Long | Equity-common | US | $2M | 160K | 1.77 |
Address
Global X Funds
1 Freedom Valley Drive
Oaks
Pennsylvania
19456
United States of America
Websites
Directors
Charles A. Baker
Luis Berruga
Clifford J. Weber
Susan M. Ciccarone
Transfer Agents
Bank of New York Mellon
Pricing Services
Pricing Direct
S&P
IHS Markit
Bloomberg
Intercontinental Exchange, Inc.
Thomson Reuters Corporation
Custodians
Bank of New York Mellon
Shareholder Servicing Agents
Bank of New York Mellon
Admins
SEI INVESTMENTS GLOBAL FUNDS SERVICES
Global X Management Company, LLC
Brokers
JP MORGAN
MIRAE ASSET SECURITIES
MACQUARIE CAPITAL
MIDWEST RESEARCH SECURITIES
CREDIT SUISSE FIRST BOSTON LLC.
MIRAMAR SECURITIES LLC
CITIGROUP
GOLDMAN SACHS & CO